Contrastive study on effects of triamcinolone acetonide and compound betamethasone in treating humeral external epicondylitis
10.3969/j.issn.1671-8348.2017.25.024
- VernacularTitle:曲安奈德与复方倍他米松治疗肱骨外上髁炎的疗效对比研究
- Author:
Jin QIN
;
Yu DU
;
Kailu LIANG
- Keywords:
triamcinolone acetonide;
compound betamethasone;
humeral external epicondylitis
- From:
Chongqing Medicine
2017;46(25):3526-3528
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical treatment effect of triamcinolone acetonide and compound betamethasone in treating humeral external epicondylitis.Methods Eighty patients with humeral external epicondylitis were selected,87 sides participated in this clinical research,and divided into the triamcinolone acetonide blocking group(40 cases,43 sides) and compound betamethasone blocking group (40 cases,44 sides).Then the two groups received triamcinolone acetonide or compound betamethasone blocking therapy respectively.The clinical treatment effects were observed and evaluated.Results The Visual Analogue Scale (VAS) score after treatment in the triamcinolone acetonide group and compound betamethasone group was obviously decreased compared with before treatment (P＜0.01),the Activities of Daily Living(ADL)score was obviously increased (P＜0.01);The difference value (improvement degree) of VAS score before and after treatment in the compound betamethasone group was obviously increased compared with the triamcinolone acetonide group (P＜0.01).Conclusion Both triamcinolone acetonide and compound betamethasone blocking treatment are effective on humeral external epicondylitis,but the curative effect of compound betamethasone is superior to that of triamcinolone acetonide.
